No abstract available
Keywords:
Class I HDAC; HDAC6; histone deacetylase inhibitors; multiple myeloma.
Publication types
-
Comparative Study
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetylation / drug effects
-
Antineoplastic Agents / pharmacology*
-
Apoptosis / drug effects*
-
Cell Line, Tumor / drug effects
-
Cell Line, Tumor / enzymology
-
Depsipeptides / pharmacology
-
Drug Screening Assays, Antitumor
-
Histone Deacetylase Inhibitors / pharmacology*
-
Histones / metabolism
-
Humans
-
Hydroxamic Acids / pharmacology
-
Indoles / pharmacology
-
Multiple Myeloma / enzymology
-
Multiple Myeloma / pathology*
-
Neoplasm Proteins / antagonists & inhibitors*
-
Panobinostat
-
Protein Processing, Post-Translational / drug effects
-
Pyrimidines / pharmacology
-
Tubulin / metabolism
-
Tumor Cells, Cultured / drug effects
-
Tumor Cells, Cultured / enzymology
Substances
-
2-((1-(3-fluorophenyl)cyclohexyl)amino)-N-hydroxypyrimidine-5-carboxamide
-
Antineoplastic Agents
-
Depsipeptides
-
Histone Deacetylase Inhibitors
-
Histones
-
Hydroxamic Acids
-
Indoles
-
N-hydroxy-2-(1-phenylcycloproylamino)pyrimidine-5-carboxamide
-
Neoplasm Proteins
-
Pyrimidines
-
Tubulin
-
Panobinostat
-
romidepsin
-
ricolinostat